{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:47:32Z","timestamp":1784602052249,"version":"3.55.0"},"reference-count":52,"publisher":"American Chemical Society (ACS)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[2014,11,13]]},"DOI":"10.1021\/jm501174m","type":"journal-article","created":{"date-parts":[[2014,10,6]],"date-time":"2014-10-06T14:25:09Z","timestamp":1412605509000},"page":"9078-9095","source":"Crossref","is-referenced-by-count":54,"title":["Novel DNA Gyrase Inhibiting Spiropyrimidinetriones with a Benzisoxazole Scaffold: SAR and in Vivo Characterization"],"prefix":"10.1021","volume":"57","author":[{"given":"Gregory S.","family":"Basarab","sequence":"first","affiliation":[{"name":"Infection Innovative Medicines, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Brassil","sequence":"additional","affiliation":[{"name":"Infection Innovative Medicines, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Doig","sequence":"additional","affiliation":[{"name":"Infection Innovative Medicines, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Galullo","sequence":"additional","affiliation":[{"name":"Infection Innovative Medicines, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard B.","family":"Haimes","sequence":"additional","affiliation":[{"name":"Infection Innovative Medicines, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunther","family":"Kern","sequence":"additional","affiliation":[{"name":"Infection Innovative Medicines, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Kutschke","sequence":"additional","affiliation":[{"name":"Infection Innovative Medicines, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McNulty","sequence":"additional","affiliation":[{"name":"Infection Innovative Medicines, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virna J. A.","family":"Schuck","sequence":"additional","affiliation":[{"name":"Infection Innovative Medicines, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Stone","sequence":"additional","affiliation":[{"name":"Infection Innovative Medicines, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhusudhan","family":"Gowravaram","sequence":"additional","affiliation":[{"name":"Infection Innovative Medicines, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2014,10,17]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ja.2013.49","volume":"67","author":"Walsh C. T.","year":"2014","journal-title":"J. Antibiot."},{"key":"ref2\/cit2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/13543784.2014.847087","volume":"23","author":"Georgopapadakou N. H.","year":"2014","journal-title":"Expert Opin. Invest. Drugs"},{"key":"ref3\/cit3","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.2174\/0929867320666131119122520","volume":"21","author":"Drebes J.","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"ref4\/cit4","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.bcp.2011.07.077","volume":"82","author":"Bush K.","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"ref5\/cit5","first-page":"283","volume-title":"Annual Reports in Medicinal Chemistry","volume":"48","author":"Hevener K. E.","year":"2013"},{"key":"ref6\/cit6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","volume":"6","author":"Payne D. J.","year":"2007","journal-title":"Nature Rev. Drug Discovery"},{"key":"ref7\/cit7","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1021\/jm100898v","volume":"53","author":"Longshaw A. I.","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref8\/cit8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nrmicro2349","volume":"8","author":"Simmons K. J.","year":"2010","journal-title":"Nature Rev. Microbiol."},{"key":"ref9\/cit9","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.4155\/fmc.10.250","volume":"2","author":"Widdowson K.","year":"2010","journal-title":"Future Med. Chem."},{"key":"ref10\/cit10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-61779-520-6_13","volume":"841","author":"Finn J.","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"ref11\/cit11","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1128\/AAC.00247-08","volume":"52","author":"Miller A. A.","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref12\/cit12","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1021\/jo00220a024","volume":"50","author":"Verboom W.","year":"1985","journal-title":"J. Org. Chem."},{"key":"ref13\/cit13","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3390\/10091101","volume":"10","author":"D\u2019yachenko E. V.","year":"2005","journal-title":"Molecules"},{"key":"ref14\/cit14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2725(08)60294-9","volume":"65","author":"Meth-Cohn O.","year":"1996","journal-title":"Adv. Heterocycl. Chem."},{"key":"ref15\/cit15","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1021\/ja808014h","volume":"131","author":"Ruble J. C.","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"ref16\/cit16","unstructured":"Barbachyn, M. R.; Dobrowolski, P. J.; Hurd, A. R.; McNamara, D. J.; Palmer, J. R.; Romero, A. G.; Ruble, J. C.; Sherry, D. A.; Thomasco, L. M.; Toogood, P. L.Preparation of thiazolylspirooxazinoquinolinepyrimidinetriones as antibacterials. PCT Patent WO 2004031195A1, 2004."},{"key":"ref17\/cit17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1517\/17460441.2012.660478","volume":"7","author":"Sanyal G.","year":"2012","journal-title":"Expert Opin. Drug Discovery"},{"key":"ref18\/cit18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1568026033452500","volume":"3","author":"Maxwell A.","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"key":"ref19\/cit19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0966-842X(96)10085-8","volume":"5","author":"Maxwell A.","year":"1997","journal-title":"Trends Microbiol."},{"key":"ref20\/cit20","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1021\/cr4003984","volume":"114","author":"Mayer C.","year":"2014","journal-title":"Chem. Rev."},{"key":"ref21\/cit21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","volume":"70","author":"Champoux J. J.","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"ref22\/cit22","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature09197","volume":"466","author":"Bax B. D.","year":"2010","journal-title":"Nature"},{"key":"ref23\/cit23","first-page":"804","volume":"10","author":"Black M. T.","year":"2009","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"ref24\/cit24","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1021\/jm800318d","volume":"51","author":"Charifson P. S.","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref25\/cit25","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1128\/AAC.49.9.3810-3815.2005","volume":"49","author":"Fujimoto-Nakamura M.","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref26\/cit26","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1016\/j.bmcl.2013.10.058","volume":"23","author":"Axford L. C.","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref27\/cit27","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1021\/jm401208b","volume":"56","author":"Basarab G. S.","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref28\/cit28","first-page":"1519","volume":"2","author":"Malik S.","year":"2010","journal-title":"J. Pharm. Res."},{"key":"ref29\/cit29","unstructured":"Barvian, K.; Basarab, G. S.; Gowravaram, M. R.; Hauck, S. I.; Zhou, F.Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections. USP 8658641, 2010."},{"key":"ref30\/cit30","unstructured":"Barbachyn, M. R.; Dobrowolski, P. J.; Hagen, S. E.; Heimbach, T. H.; Hurd, A. R.; Johnson, T. A.; McNamara, D. J.; Ruble, J. C.; Sherry, D. A.; Thomasco, L. M.; Toogood, P. L.PCT Patent WO 2006120563 A2, 2006."},{"key":"ref31\/cit31","unstructured":"Johnson, T. A.; Sherry, D. A.; McNamara, D. J.; Toogood, P. L.Preparation of 8-pyrazinyl 5-spiropyrimidinetrione-oxazinoquinoline compounds as antibacterial agents. PCT Patent WO 2007072151, 2007."},{"key":"ref32\/cit32","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.1016\/S0040-4039(00)60805-5","volume":"33","author":"Bridges A. J.","year":"1992","journal-title":"Tetrahedron Lett."},{"key":"ref33\/cit33","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1002\/cber.19671001022","volume":"100","author":"B\u00f6shagen H.","year":"1967","journal-title":"Chem. Ber."},{"key":"ref34\/cit34","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/jlac.198119810824","volume":"1981","author":"Geffken D.","year":"1981","journal-title":"Liebigs Ann. Chem."},{"key":"ref35\/cit35","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/1087057110378624","volume":"15","author":"Shapiro A.","year":"2010","journal-title":"J. Biomol. Screening"},{"key":"ref36\/cit36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-012-0018-5","volume":"52","author":"Roberts J.","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"ref37\/cit37","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/jps.21958","volume":"99","author":"Berezhkovskiy L. M.","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"ref38\/cit38","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1021\/jm401208b","volume":"56","author":"Basarab G. S.","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref39\/cit39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1517\/17460441.2.1.51","volume":"2","author":"Trainor G. L.","year":"2007","journal-title":"Expert Opin. Drug Discovery"},{"key":"ref40\/cit40","first-page":"557","volume-title":"Introduction to the Principles of Drug Design and Action","author":"Russell A. D.","year":"2005","edition":"4"},{"key":"ref41\/cit41","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.bmcl.2014.03.022","volume":"24","author":"Perola E.","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref42\/cit42","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1128\/AAC.43.7.1693","volume":"43","author":"Hilliard J. J.","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref43\/cit43","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/AAC.00596-06","volume":"51","author":"Grossman T. H.","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref44\/cit44","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijantimicag.2012.12.001","volume":"41","author":"Uria-Nickelsen M.","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"14","key":"ref45\/cit45","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1128\/jb.177.14.4166-4170.1995","volume":"177","author":"Munoz R.","year":"1995","journal-title":"J. Bacteriol."},{"key":"ref46\/cit46","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1128\/AAC.45.10.2755-2764.2001","volume":"45","author":"Ince D.","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref47\/cit47","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bjc.6600079","volume":"86","author":"Herold C.","year":"2002","journal-title":"Br. J. Cancer"},{"key":"ref48\/cit48","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.bcp.2013.02.006","volume":"85","author":"Shapiro A. B.","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref49\/cit49","unstructured":"Biwersi, C.; Tecle, H.; Warmus, J. S.PCT Patent WO 2001068619, 2001."},{"key":"ref50\/cit50","unstructured":"Clinical and Laboratory Standards Institute Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically;Approved Standard M07-A9Clinical and Laboratory Standards Institute:Wayne, PA, 2012; Vol.42, pp88."},{"key":"ref51\/cit51","unstructured":"Performance Standards for Antimicrobial Susceptibility Testing;24th Informational Supplement M100-S24;Clinical and Laboratory Standards Institute:Wayne, PA, 2014; Vol.34, pp10."},{"key":"ref52\/cit52","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1128\/AAC.00226-09","volume":"53","author":"de Jonge B. L. M.","year":"2009","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/jm501174m","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T08:42:22Z","timestamp":1682239342000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/jm501174m"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,17]]},"references-count":52,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2014,11,13]]}},"alternative-id":["10.1021\/jm501174m"],"URL":"https:\/\/doi.org\/10.1021\/jm501174m","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,17]]}}}